bpc-157 human clinical trial interstitial cystitis and the Difference Between an Evidence Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded Effect of BPC-157 on Symptoms

AI-powered assistance: Get answers to your specific questions about peptides, managing side effects, optimizing protocols, and making informed decisions

Higher is not always better: 9 mg often delivers a better efficacy-to-tolerability ratio than 12 mg

Eur J Pharmacol 131:105109, 1986 Sikiric P, Rotkvic I, Mise S, Krizanac S, Gjuris V, Jukic J, Suchanek E, Petek M, Udovicic I, Kalogjera L, Geber J, Tucan-Foretic M, Duvnjak M, Philipp M, Balen I, Anic T: The influence of dopamine agonists and antagonists on indomethacin lesions in stomach and small intestine in rats

They have step-by-step guides

doi: 10.1016/S0169-328X(98)00142-9